Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Perel

Showing results (51-60 of 240) with videos related to

Pageof 24
Sort By:
Psychopharmacology Bulletin|July 1, 1980
Pharmacological factors of methylphenidate metabolism in behaviorally disordered childrenB G Winsberg, B L Hungund, J M Perel
Thrombosis Et Diathesis Haemorrhagica|August 31, 1972
Inhibition of thromboplastin activity in plasma by aluminosilicate treatmentT Chenkin, D Moses, J M Perel, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|May 7, 1999
Mood stabilizers in children and adolescentsN D Ryan, V S Bhatara, J M Perel
Clinical Pharmacology and Therapeutics|August 1, 1978
Effect of human growth hormone on amobarbital metabolism in childrenG P Redmond, J J Bell, J M Perel
Journal of Psychiatric Research|January 1, 1993
Imipramine treatment of panic disorder with agoraphobia: the second time aroundM R Mavissakalian, J M Perel, C de Groot
Expert Review of Neurotherapeutics|October 9, 2009
Bupropion for attention deficit hyperactivity and comorbid disordersW Burleson Daviss, Raymond J Pan, James M Perel
Journal of Geriatric Psychiatry and Neurology|October 1, 1990
Pharmacodynamic issues relevant to geriatric psychopharmacologyB G Pollock, J M Perel, C F Reynolds
Annals of the New York Academy of Sciences|November 26, 1973
Influence of binding on drug metabolism and distributionP G Dayton, Z H Israili, J M Perel
The American Journal of Psychiatry|January 4, 2001
Paroxetine in breast milkK L Wisner, R L Findling, J M Perel
Communications in Psychopharmacology|January 1, 1978
Studies on plasma level/effect relationships in imipramine therapyJ M Perel, R L Stiller, A H Glassman
Pageof 24

Showing results (51-60 of 240) with videos related to

Sort By:
Pageof 24
Psychopharmacology Bulletin|July 1, 1980
Pharmacological factors of methylphenidate metabolism in behaviorally disordered childrenB G Winsberg, B L Hungund, J M Perel
Thrombosis Et Diathesis Haemorrhagica|August 31, 1972
Inhibition of thromboplastin activity in plasma by aluminosilicate treatmentT Chenkin, D Moses, J M Perel, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|May 7, 1999
Mood stabilizers in children and adolescentsN D Ryan, V S Bhatara, J M Perel
Clinical Pharmacology and Therapeutics|August 1, 1978
Effect of human growth hormone on amobarbital metabolism in childrenG P Redmond, J J Bell, J M Perel
Journal of Psychiatric Research|January 1, 1993
Imipramine treatment of panic disorder with agoraphobia: the second time aroundM R Mavissakalian, J M Perel, C de Groot
Expert Review of Neurotherapeutics|October 9, 2009
Bupropion for attention deficit hyperactivity and comorbid disordersW Burleson Daviss, Raymond J Pan, James M Perel
Journal of Geriatric Psychiatry and Neurology|October 1, 1990
Pharmacodynamic issues relevant to geriatric psychopharmacologyB G Pollock, J M Perel, C F Reynolds
Annals of the New York Academy of Sciences|November 26, 1973
Influence of binding on drug metabolism and distributionP G Dayton, Z H Israili, J M Perel
The American Journal of Psychiatry|January 4, 2001
Paroxetine in breast milkK L Wisner, R L Findling, J M Perel
Communications in Psychopharmacology|January 1, 1978
Studies on plasma level/effect relationships in imipramine therapyJ M Perel, R L Stiller, A H Glassman
Pageof 24